NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Postmortem delay has minimal effect on brain RNA integrity.

Author(s): Ervin JF, Heinzen EL, Cronin KD, Goldstein D, Szymanski MH, Burke JR, Welsh-Bohmer KA, Hulette CM

Publication: J Neuropathol Exp Neurol, 2007, Vol. 66, Page 1093

PubMed ID: 18090918 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to asses the effect, if any, of several antemortem and postmortem variables (such as postmortem interval, agonal state, ventricular cerebrospinal fluid pH, and cause of death) on RNA integrity in multiple brain regions.

Conclusion of Paper

RNA quality was not affected by the clinical variables investigated. The authors conclude that RNA of sufficient quality for molecular analysis may be isolated from most brain regions up to 30 hours after death.

Studies

  1. Study Purpose

    The purpose of this study was to asses the effect, if any, of several antemortem and postmortem variables (such as postmortem interval, agonal state, ventricular cerebrospinal fluid pH, and cause of death) on RNA integrity in multiple brain regions. Beta-actin and GAPDH mRNA were evaluated from frontal cortex, temporal cortex, occipital cortex, cerebellum, and hippocampus biospecimens.

    Summary of Findings:

    The authors report finding no correlations between the variables measured and the percentage of intact RNA isolated. A slight correlation was observed between patient age and pH of the postmortem ventricular fluid.

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Alzheimer's Disease
    • Autopsy
    • Not specified
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    RNA Spectrophotometry
    RNA Electrophoresis
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Diagnosis/ patient condition Alzheimer's disease
    Matched non-Alzheimer's control
    Preaquisition Patient genotype ApoE status 22
    ApoE status 23
    ApoE status 24
    ApoE status 33
    ApoE status 34
    ApoE status 44
    Preaquisition Patient age 56 - 103 years
    Preaquisition Patient gender Female
    Male
    Storage Storage duration 0.6 - 19.2 years
    Preaquisition Postmortem interval 40 min. - 30 h
    Biospecimen Acquisition Biospecimen location Frontal cortex
    Temporal cortex
    Occipital cortex
    Cerebellum
    Hippocampus
    Preaquisition Diagnosis/ patient condition Fever
    No fever
    Preaquisition Diagnosis/ patient condition Sepsis
    No sepsis
    Preaquisition Diagnosis/ patient condition Drug use
    No drug use
    Preaquisition Diagnosis/ patient condition Provision of supplemental oxygen in agonal period
    No supplemental oxygen in agonal period
    Preaquisition Cause of death Pneumonia
    Urinary tract infection
    Myocardial infarction
    Metastatic cancer
    Cardiopulmonary arrest
    Dehydration
    Cancer
    Biospecimen Aliquots and Components pH Ventricular fluid pH 6.26 - 8.0

You Recently Viewed  

News and Announcements

  • Most Downloaded SOPs in 2024

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • More...